Larvol Delta - A-Study-of-the-Drug-Letermovir-LTV-as-Prevention-for-Recurrent-of-Cytomegalovirus-CMV-Infection

Prevymis (letermovir) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT04017962

Jul 30, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next